RESUMO
To address workplace violence, says the author, healthcare facilities must employ a proactive and multidisciplinary approach. Leadership commitment, training and education, communication, assistance initiatives, policies and procedures, and effective use of security are crucial.
Assuntos
Medidas de Segurança , Violência/prevenção & controle , Local de Trabalho , Humanos , Saúde Ocupacional , Medição de Risco , Estados UnidosAssuntos
Planejamento em Desastres/normas , Guias como Assunto , Administração Hospitalar/normas , Emergências , Incêndios/prevenção & controle , Joint Commission on Accreditation of Healthcare Organizations , Técnicas de Planejamento , Medidas de Segurança/normas , Sociedades , Estados Unidos , United States Occupational Safety and Health AdministrationRESUMO
Seventy patients with rheumatoid arthritis (RA) completing a 12-week multicenter double blind trial comparing recombinant human interferon-gamma (r-IFN-gamma) with placebo were enrolled in a longterm prospective protocol evaluating r-IFN-gamma in RA. Forty (57%) patients after 1 year and 26 (37%) patients after 2 years continued the drug with sustained clinical benefit. Over 2 years, r-IFN-gamma was discontinued in 44 patients (lack of efficacy--25, withdrawn consent--7, noncompliant--4, suspected adverse drug reactions--2, concurrent illness--6). Two years of treatment with r-IFN-gamma were well tolerated with sustained clinical benefit in some patients with few significant adverse drug reactions.
